These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1377 related items for PubMed ID: 9887430
21. Sjögren's syndrome: histologic and immunohistochemical study. Huguet P, Bosch JA, Raventós A, Jacas C, Sanjosé A, Vilardell M. Ann Med Interne (Paris); 1995; 146(4):233-4. PubMed ID: 7653941 [Abstract] [Full Text] [Related]
23. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, Patsouris E, Moutsopoulos HM. Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195 [Abstract] [Full Text] [Related]
24. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection. Coll J, Gambús G, Corominas J, Tomás S, Esteban JI, Guardia J. Ann Rheum Dis; 1997 Jun; 56(6):390-2. PubMed ID: 9227171 [Abstract] [Full Text] [Related]
25. [Immunopathology of the salivary glands of the lips in Sjögren's syndrome]. Dalabanga YA, Drosos AA, Moutsopoulos HM. Ter Arkh; 1988 Jun; 60(4):35-8. PubMed ID: 3260693 [Abstract] [Full Text] [Related]
27. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome. Ek M, Popovic K, Harris HE, Nauclér CS, Wahren-Herlenius M. Arthritis Rheum; 2006 Jul; 54(7):2289-94. PubMed ID: 16802368 [Abstract] [Full Text] [Related]
28. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933 [Abstract] [Full Text] [Related]
36. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. Katano K, Kawano M, Koni I, Sugai S, Muro Y. J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163 [Abstract] [Full Text] [Related]
37. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies. Willeke P, Gaubitz M, Schotte H, Becker H, Mickholz E, Domschke W, Schlüter B. Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916 [Abstract] [Full Text] [Related]
38. [Cell-mediated immunity in patients with Sjogren's syndrome]. Krejsek J, Slezák R, Kopecký O, Vokurková D, Loudová M, Derner V. Cas Lek Cesk; 1997 Jan 22; 136(2):44-7. PubMed ID: 9147852 [Abstract] [Full Text] [Related]
39. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, Reis BL, Whitcup SM, Thompson D, Smith JA. Invest Ophthalmol Vis Sci; 2002 Aug 22; 43(8):2609-14. PubMed ID: 12147592 [Abstract] [Full Text] [Related]